Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study.

The aim of this multinational retrospective cohort study, conducted at academic and community oncology centres, was to describe real-world treatment patterns for patients with a confirmed diagnosis of advanced/metastatic (stage IIIB/IV) non-small cell lung cancer (NSCLC) who initiated first-line systemic therapy from January 2011 through June 2014. The study included 1265 patients in Italy, Spain, Germany, Australia, Korea, Taiwan and Brazil. The proportion of patients with squamous versus non-squamous NSCLC was approximately 20% versus 75%, and associated patient demographic characteristics were similar in all countries, excepting race. Patients with squamous NSCLC were predominantly male and current/ex-smokers. Biomarker tests were performed for the majority of patients with non-squamous NSCLC, ranging from 54% (Brazil) to 91% in Taiwan, where, of those tested, 68% with non-squamous NSCLC had positive epidermal growth factor receptor (EGFR)-mutation status; in other countries the EGFR-positive percentages ranged from 17% (Spain/Brazil) to 40% (Korea). Platinum-based regimens were the most common first-line therapy in all countries except Taiwan, where gefitinib was the most common first-line agent. Median overall survival ranged from 9.3 months (Brazil) to 25.5 months (Taiwan). The diagnostic and treatment patterns recorded in this study were heterogeneous but largely in line with NSCLC guidelines during the study period.

An Assessment of HIV-Infected Patients Dying in Care for Deceased Organ Donation in a United States Urban Center.

Organ transplantation is an acceptable option for human immunodeficiency virus (HIV)-infected patients with end-stage kidney or liver disease. With worse outcomes on the waitlist, HIV-infected patients may actually be disproportionately affected by the organ shortage in the United States. One potential solution is the use of HIV-infected deceased donors (HIVDD), recently legalized by the HIV Organ Policy Equity (HOPE) Act. This is the first analysis of patient-specific data from potential HIVDD, retrospectively examining charts of HIV-infected patients dying in care at six HIV clinics in Philadelphia, Pennsylvania from January 1, 2009 to June 30, 2014. Our data suggest that there are four to five potential HIVDD dying in Philadelphia annually who might yield two to three kidneys and three to five livers for transplant. Extrapolated nationally, this would approximate 356 potential HIVDD yielding 192 kidneys and 247 livers annually. However, several donor risk indices raise concerns about the quality of kidneys that could be recovered from HIVDD as a result of older donor age and comorbidities. On the other hand, livers from these potential HIVDD are of similar quality to HIV-negative donors dying locally, although there is a high prevalence of positive hepatitis C antibody.

Investigation of genotype x country interactions for growth traits in beef cattle.

The importance of genotype x country interactions for weaning and birth weight and postweaning gain between Argentina (AR), Canada (CA), Uruguay (UY), and the United States (US) for populations of Hereford cattle was investigated. Three sample data sets of computationally manageable sizes were formed for each trait and pairwise combination of countries to investigate possible interactions. Parameters were estimated for each sample data set via an accelerated EM-REML algorithm and multiple-trait animal models that considered either weaning or birth weight as a different trait in each country. Direct and maternal (in parentheses) weaning weight genetic correlation estimates for AR-CA, AR-UY, AR-US, CA-UY, CA-US, and UY-US were 0.82 (0.80), 0.81 (0.72), 0.81 (0.79), 0.83 (0.78), 0.85 (0.82), and 0.86 (0.81), respectively. Direct and maternal (in parentheses) birth weight genetic correlation estimates were 0.92 (0.62), 0.97, (0.85), and 0.99 (0.97) for AR-CA, AR-US, and CA-US, respectively. Birth weight was not analyzed for UY due to small amounts of data. Postweaning gain in CA and US was 160-d gain, and in AR and UY 345-d gain was used. Across-country direct genetic correlations for postweaning gain were estimated for each pairwise country data set using a model that considered weaning weight as the same trait across each country, whereas postweaning gain was treated as a different trait in each country. Direct genetic correlation estimates for postweaning gain for AR-CA, AR-UY, AR-US, CA-UY, CA-US, and US-UY were 0.64, 0.80, 0.51, 0.84, 0.92, and 0.83, respectively. The overall results indicate that weaning and birth weights of Hereford calves can be analyzed as the same trait in all countries with a common set of heritabilities and genetic correlations, after adjustment for heterogenous phenotypic variances across countries. Postweaning gain in CA and US can be considered as the same trait and analyzed using a single set of parameters. Postweaning gain in AR and UY should be considered as a separate trait from postweaning gain in CA and US, and postweaning gain in AR and UY can be considered as the same trait and analyzed using a common heritability, after adjustment for phenotypic variance differences between the two countries.